Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid

NCT02719327 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

131

Enrollment

FED

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: icosapent ethyl (IPE)
OTHER: gel cap placebo

Sponsor

VA Office of Research and Development

Collaborators

[object Object]